Core Scientific, Inc.'s Chief Legal and Administrative Officer, Todd M. Duchene, recently completed a stock sale that involved the disposition of 10,000 shares of the company's common stock on May 26, 2026. The aggregate value realized from these transactions was $262,540.
The sale details indicate that the weighted average price per share for Mr. Duchene was $26.254. Individual transaction prices observed during the sale ranged between $25.81 and $26.75. It is important to note that this divestment was structured under a Rule 10b5-1 trading plan, which Mr. Duchene had initially established on December 5, 2025.
The timing of this reported sale coincides with movements in the company's stock price. Core Scientific shares are currently trading close to their 52-week high of $27.70. This level follows a substantial performance period for the stock, which has reportedly delivered a 153% return over the preceding year and an 87% gain year-to-date.
Despite the strong recent market performance, some valuation analysis suggests caution. Specifically, according to InvestingPro's analysis, the stock currently appears to be valued above its calculated Fair Value.
Operational Updates and Financial Reporting
Beyond the insider activity, Core Scientific provided updates on both its finances and strategic direction. The company released its Q1 2026 earnings report, which presented a mixed financial picture. While revenue reached $115.24 million USD, the company posted a loss, with Earnings Per Share (EPS) recorded at -1.06 USD.
The reported figures suggest an operational transition within the firm. The data indicates a strategic shift in focus from traditional Bitcoin mining activities toward developing colocation infrastructure services.
In parallel, the financial community provided positive commentary on the company's trajectory. BTIG elevated its price target for Core Scientific to $33 from an earlier level of $23, maintaining a 'Buy' rating. This upgrade was attributed in part to the company's expansion efforts, specifically noting that Core Scientific plans to increase its power capacity by incorporating approximately 1.2 gigawatts this year. This planned growth includes establishing a new facility with a capacity of 430 megawatts in Hunt County, Texas.
Corporate Governance and Strategic Initiatives
Core Scientific also convened its 2026 Annual Meeting of Stockholders. During this meeting, five new individuals were elected to the board of directors, with terms set until the 2027 meeting.
Furthermore, a key appointment was announced: Steve Smith was named to the board of directors and will serve on the Nominating and Corporate Governance Committee. Mr. Smith brings substantial professional experience to the role, possessing over 35 years in various sectors including data center operations, digital infrastructure development, and technology services.
These multiple developments - encompassing strategic power capacity expansion, board governance changes, and financial reporting - underscore Core Scientific's ongoing operational adjustments and commitment to evolving its business model. Following the transaction, Mr. Duchene continues to hold 2,088,895 shares of Core Scientific common stock.